medigraphic.com
ISSN 0138-7103 (Print)

2014, Number 2

Next >>

Revista del Hospital Psiquiátrico de La Habana 2014; 11 (2)

Cognitive changes on the multiple sclerosis

Rodríguez LG, Olivera LIR, Peñalver PM

Language: Spanish
References: 20
Page:
PDF size: 186.57 Kb.


ABSTRACT

Introduction: The Multiple Sclerosis (EM) frequently increases with cognitive impairment; the identification of the main changes help the rehabilitation of these patients and also delay or stop the increscent of the impairment caused by the illness.
Objective: To identify the presence of cognitive changes on patients with Multiple Sclerosis.
Patients and Methods: A transversal and descriptible study was done on cases of control and on patients with EM that came to the Demyelinated Diseases Appointments from theHermanos Ameijeiras Clinical –Surgery Hospital, Havana during a period from January, 2011 to November, 2013.The studied group with EM was formed by 48 individuals and the control by 28 healthy persons that reached a scholar level higher than 9th grade from 18 to 60 years old and both sexes. MoCa Test was the measure instrument used for the cognitive impairment.
Results: The standard assessment obtained during the MoCa test was on patients with EM and on the control was 25.1 and 28,3 respectively that represent a relevant difference between both groups (p=0,000). The sieving of the deficits due to cognitive problems showed changes between the individuals with EM on memory 95.8%, attention 70.8% and visuospatial processing 81.8%.
Conclusions: The cognitive impairment on patients with EM was high. The visuospatial function and the memory were more affected on patients with EM.


REFERENCES

  1. Compston A, Coles A. Multiplesclerosis. Lancet 2008; 372 (9648): 1502–17.

  2. Bruck W, Stadelmann C. Infammation and degeneration in multiple sclerosis. NeurolSci 2003; 24(suppl 5):265-7.

  3. Dutta R, Trapp BD. Pathogenesis of axonal and neuronal damage in multiple sclerosis. Neurology 2007; 68(suppl 3):22-31.

  4. Compston A, Coles A. Multiple sclerosis. Lancet 2002359 (9313): 1221–31

  5. Mc Donald WI, Compston A, Edan G, Goodkin D, Hartung HP, Lublin FD, McFarland HF, Paty DW, Polman CH, Reingold SC, Sandberg-Wollheim M, Sibley W, Thompson A, van den Noort S, Weinshenker BY, Wolinsky JS. Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the diagnosis of multiple sclerosis. Ann Neurol. 2001 Jul; 50(1):121-7.

  6. Fernández Liguori N, Katz O. Manejo sintomático. En A. Villa, J. Correale y O. Garcea (Eds.), Esclerosis Múltiple. Conceptos básicos y clínicos. Buenos Aires: Editorial Dunken; 2008:279-300.

  7. Trojano M, Paolicelli D. The differential diagnosis of multiple sclerosis: classification and clinical features of relapsing and progressive neurological syndromes. Neurol. Sci. 2011; 22 (Suppl 2): 98–102.

  8. Charcot JM. Lectures on the diseases of the nervous system delivered at La Salpetriere. London: New Sydenham Society; 1877.

  9. Rao SM, Leo GJ, Bernardin L, Unverzag F. Cognitive dysfunction in multiple sclerosis. I. Frecuency, patterns and prediction. Neurology 1991; 41 (5): 685-91.

  10. Nasreddine ZS, Phillips NS, Bédirian V, Charbonneau S, Whitehead V, Collin I, et al. The Montreal Cognitive Assessment, MoCA: A brief screening tool for mild cognitive impairment. Journal of the American Geriatrics Society. 2005; 53(4), 695-9.

  11. Lozano Gallego M, Hernández Ferrándiz M, Turró Garriga O, Pericot Nierga I, López-Pousa S, Vilalta Franch J.Validación del MoCA: Test de cribado para el deterioro cognitivo leve. Datos preliminares. Alzheimer. 2009 Sep; (43):4-11.

  12. Mineev KK, Prakhova LN, Il'ves AG, Kataeva GV, Petrov AM, Reznikova TN, Pozdnyakov AV, Stolyarov ID. Characteristics of neurological and cognitive status in patients with multiple sclerosis in relation to the location and volumes of demyelination foci and the severity of brain atrophy. NeurosciBehav Physiol. 2009; 39(1):35-8.

  13. Courtney SM. Understanding cognitive dysfunction in multiple sclerosis: integrating a firstperson perspective with neuropsychological testing, neuroimaging, and cognitive neuroscience research. Cogn Behav Neurol. 2011 Dec; 24(4):227-30.

  14. Sánchez Lopez MP. Neuropsicologia de la esclerosis múltiple: estudio de la afectación neuropsicológica, su relación con los parámetros de RM y evolución (tesis doctoral). Servicio de publicaciones. Universidad de la Laguna; 2006.

  15. Rao SM, Leo GJ, Bernardin L, Unverzag F. Cognitive dysfunction in multiple sclerosis. I. Frecuency, patterns and prediction. Neurology 1991; 41 (5): 685-91.

  16. Zivadinov R, Sepcić J. Impairment in multiple sclerosis patients. Lijec Vjesn. 2004 Jul-Aug; 126(7-8):204-10.

  17. Vicens A, de Castro P. Funciones cognitivas en la esclerosis múltiple. Revisión bibliográfica (1980-1991). Neurología 1992; 7 (7): 185-9.

  18. Rao S.M. Neuropsychology of multiple sclerosis: a critical review. J ClinExpNeuropsychol 1986; 8 (5):503-42.

  19. Gaudino EA, Chiaravalloti ND, Deluca J, Diamond BJ. A comparison of memory performance in relapsing-remitting, primary progressive andsecondary progressive, multiple sclerosis. J Neuropsychiatry Neuropsychol Behav Neurol 2001; 14: 32-44.

  20. Arango-Lasprilla JC, DeLuca J, Chiaravalloti NEl perfil neuropsicológico en la esclerosis múltiple. Psicothema. 2007.19, (1): 1-6.




2020     |     www.medigraphic.com